Frontiers in Oncology | Breast Cancer

Original Research

Published on 22 May 2025

Electroacupuncture combined with HDAC1 inhibitor suppress tumor growth via improving the recruitment of intratumor CD8+ T cells for triple-negative breast cancer in mice

in Breast Cancer

Yehong Tian
Yinjie Ma
Xue Li
Gang Lu
Shixin Wang
Xiaowei Qiu
Xu Du

Frontiers in Oncology

doi 10.3389/fonc.2025.1584722

537 views

Case Report

Published on 22 May 2025

Case Report: Primary leiomyosarcoma of the breast

in Breast Cancer

Haoqiang Lv
Haiyang Ren
Shuang Zhang
Gen Ding
Ping Tian

Frontiers in Oncology

doi 10.3389/fonc.2025.1571029

513 views

Original Research

Published on 21 May 2025

External validation of the Oncotype DX breast cancer recurrence score nomogram and development and validation of a novel machine learning-based model to predict postoperative overall survival and guide adjuvant chemotherapy in ER positive, Her-2 negative breast cancer patients: a retrospective cohort study

in Breast Cancer

Dongdong Wang
Xinfeng Wang
Xin Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1586262

509 views

Original Research

Accepted on 20 May 2025

Survival Prognosis Evaluation in Advanced Breast Cancer Patients: A Study on the Application of the Advanced Lung Cancer Inflammation Index

in Breast Cancer

Chunfeng Liang
Chunyan Yang
QiuJiao Yang
Yuchen Tang
Wenhai Zhang
Qixing Tan
Qinghong Qin

Frontiers in Oncology

doi 10.3389/fonc.2025.1598069

121 views

Original Research

Accepted on 20 May 2025

HER2 and hormone receptor conversion after neoadjuvant therapy for breast cancer

in Breast Cancer

Jing Wang
Xin Long
Mingxi Tang
Xiuli Xiao

Frontiers in Oncology

doi 10.3389/fonc.2025.1522460

125 views

Original Research

Accepted on 20 May 2025

Prediction of HER2 expression in breast cancer patients based on multi-parametric MRI intratumoral and peritumoral radiomics features combined with clinical and imaging indicators

in Breast Cancer

Xiaoxiao Li
Junfang Fang
Fuqian Wang
Lin Zhang
Xingyue Jiang
Xijin Mao

Frontiers in Oncology

doi 10.3389/fonc.2025.1531553

125 views

Original Research

Accepted on 20 May 2025

Therapeutic Potential of Grape Seed Proanthocyanidin Extract in Enhancing Lymphatic and Blood Flow in Secondary Lymphedema Models

in Breast Cancer

Hwayeong Cheon
Bumchul Kim
Jae Yong Jeon

Frontiers in Oncology

doi 10.3389/fonc.2025.1553090

108 views

Original Research

Accepted on 20 May 2025

Tumor-derived exosomal lncRNA SNHG4 promotes triple-negative breast cancer progression by targeting XPO5

in Breast Cancer

Zhi-Wen Wang
Hou-Sheng Yang
Hong-Shan Guo
Yue-Ying Li
Jin-Yun Zhong
Shu Jiang
Jiapeng Li
Jun Wang
Zhong-Yi Yang
Xing-Hua Liao

Frontiers in Oncology

doi 10.3389/fonc.2025.1593827

149 views

Original Research

Published on 20 May 2025

Ferroptosis-related gene signature-based subtype identification of triple-negative breast cancer to prioritize treatment strategies

in Breast Cancer

Yongzhen Chen
Xiaoying Huang
Junqi Wang
Chao Hu
Yanan Zheng
Yumeng Wang
Shuqian Zheng
Guozhong Ji
Qiang You

Frontiers in Oncology

doi 10.3389/fonc.2025.1541119

517 views

Original Research

Published on 20 May 2025

Engineered celastrol liposomes with glycyrrhizic acid augment synergistic antitumor efficacy in breast cancer

in Breast Cancer

Wei Zhang
Jiping Li
Xiuli Gao
Likun Liu
Hong Liang
Liling Yue

Frontiers in Oncology

doi 10.3389/fonc.2025.1602585

431 views

Original Research

Published on 20 May 2025

Clinical value of quantitative analysis of Sonazoid-contrast enhanced ultrasound combined with shear wave elastography in discriminating and diagnosing breast tumor characteristics

in Breast Cancer

Gang Wang
Yingmei Ouyang
LiTao Ruan

Frontiers in Oncology

doi 10.3389/fonc.2025.1485671

393 views

Review

Published on 20 May 2025

Cryoablation in the treatment of early breast cancer: a comprehensive analysis

in Breast Cancer

Yanli Xing
Hongmei Li
Ting Yuan
Xiaojiao Zou
Bing Liang
Yangyang Ma
Lizhi Niu

Frontiers in Oncology

doi 10.3389/fonc.2025.1469684

301 views

Systematic Review

Accepted on 19 May 2025

Efficacy and safety of PI3K inhibitors combined with fulvestrant for HR+/HER2-advanced breast cancer: a systematic review and metaanalysis

in Breast Cancer

Xuefeng Li
Hongxian Wang
Shuhui Lin
Tianwen Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1556978

Case Report

Accepted on 19 May 2025

Case Report of Concurrent Ulcerative Colitis and Bilateral Breast Cancer: A Literature Review of the Bidirectional Association Between Autoimmune Diseases and Breast Cancer

in Breast Cancer

Xiao Qi
Miao Zhang
Jinhong Zhu
Huaqing Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1495731

147 views

Original Research

Accepted on 16 May 2025

Combination of Ultrasound-Based Radiomics and Deep Learning with Clinical Data to Predict Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

in Breast Cancer

Liu Xinyi
Wu Tenghui
Si Ziyi
Zhang Yanting
Ma Ziqian
Zhu Yiwen
Gan Ling

Frontiers in Oncology

doi 10.3389/fonc.2025.1525285

215 views

Case Report

Accepted on 16 May 2025

Multiple drug resistance caused by germline mutation of exon 27 of BRCA2 gene in triple-negative breast cancer: a case report and literature review

in Breast Cancer

Yuting Li
Guojie Xu
Liling Zhang
Kewei Zhao
Yanxia Zhao
Dan Han

Frontiers in Oncology

doi 10.3389/fonc.2025.1602870

111 views